Dipeptidyl Peptidase-4 (DPP-4): A Multidisciplinary Hub Transcending Diabetes for Innovative Life Science Research

Published by ANT BIO PTE. LTD.

Concept

Dipeptidyl peptidase-4 (DPP-4), also known as cluster of differentiation 26 (CD26), is a multifunctional serine protease that acts as a critical molecular regulator at the intersection of metabolism, immunity, inflammation, and cancer. Beyond its well-established role in glucose homeostasis, DPP-4 functions by cleaving N-terminal dipeptides from a broad range of substrates, including incretins, chemokines, neuropeptides, and immunomodulatory factors. As both an ectoenzyme and a soluble plasma protein, DPP-4 governs diverse physiological processes and represents a highly dynamic target for translational research and therapeutic development.

[Image Location: DPP-4 Inhibitors Clinical Applications and Safety Profile Diagram]

Research Frontier

DPP-4 has evolved from a diabetes-focused drug target to a high-impact research hotspot spanning immunology, neurobiology, oncology, and gut-brain axis signaling. Emerging evidence reveals its non-canonical functions in T-cell activation, immune cell trafficking, tumor microenvironment remodeling, epithelial-mesenchymal transition (EMT), and neurodegenerative disease progression. Novel directions include substrate-selective modulation, non-enzymatic regulatory mechanisms, tissue-specific targeting, and soluble DPP-4 (sDPP-4) as a diagnostic biomarker. This multidisciplinary convergence has established DPP-4 as a priority theme in innovative scientific funding programs worldwide.

Research Significance

DPP-4 serves as an essential regulatory node in multiple disease-relevant pathways. Dysregulation is linked to type 2 diabetes, autoimmune disorders, chronic inflammation, neurological diseases, and cancer progression. By precisely modulating substrate availability and protein-protein interactions, DPP-4 shapes immune surveillance, metabolic homeostasis, neural function, and tumor biology. Robust research tools enable mechanistic dissection, biomarker discovery, and drug development — making DPP-4 a cornerstone for understanding complex disease networks and designing next-generation precision therapies.

Related Mechanisms and Research Applications

Core Biological Mechanisms

1. Metabolic Regulation

DPP-4 degrades GLP-1 and GIP, controlling insulin secretion, satiety, and glucose balance.

2. Immune Modulation (CD26)

Acts as a co-stimulatory molecule for T-cell activation; cleaves chemokines to regulate immune cell migration and balance pro- and anti-inflammatory responses.

3. Gut-Brain Axis Signaling

Modulates neuropeptides involved in mood, cognition, pain, and neural plasticity; influences central and peripheral metabolic crosstalk.

4. Tumor Regulation

Exhibits context-dependent roles: suppresses or promotes cancer progression via EMT, signaling pathway activation, and immune microenvironment remodeling.

5. Non-Enzymatic Functions

Serves as a scaffold protein through interactions with adenosine deaminase (ADA), caveolin-1, and extracellular matrix components.

Key Research Methods

• Immunodetection: IHC, WB, IF for localization and expression quantification
• Activity assays: Fluorometric and colorimetric DPP-4 enzymatic activity analysis
• Protein interaction: Co-IP, pull-down, FRET for binding partners
• Quantitative detection: ELISA for soluble DPP-4 and substrate fragments
• Disease modeling: in vivo pharmacology, organoids, and clinical cohort profiling

ANTBIO Product Empowerment

ANT BIO PTE. LTD. provides a complete DPP-4 research toolkit to accelerate mechanistic and translational studies:

• DPP-4 / CD26 Antibodies (Starter)

Validated for IHC, WB, IF, and flow cytometry; high specificity, low cross-reactivity.

• Human/Murine DPP-4 ELISA Kits (Absin)

Sensitive quantification of soluble and tissue DPP-4 in serum, plasma, cell lysates.

• Recombinant DPP-4 Protein (UA)

Bioactive full-length protein for enzymatic assays and inhibitor screening.

• General Research Reagents (Absin)

Buffers, substrates, and detection reagents optimized for DPP-4 functional studies.

These tools enable consistent, reliable results across metabolism, immunology, oncology, and neuroscience applications.

Brand Mission

ANT BIO PTE. LTD. is committed to advancing global life science discovery through high-quality, reliable reagents tailored to multidisciplinary research. Our integrated portfolio of antibodies, recombinant proteins, ELISA kits, and universal reagents empowers scientists to unravel complex biological networks, validate therapeutic targets, and translate basic insights into clinical impact. We stand as a trusted partner in driving innovation across metabolism, immunity, cancer, and neurobiology.

Related Product List

1. DPP-4 / CD26 Monoclonal Antibody

Catalog No.: S0Bxxxx

Applications: WB, IHC, IF, Flow Cytometry

Reactivity: Human, Mouse, Rat

2. Human DPP-4 ELISA Kit

Catalog No.: abs551xxx

Sample: Serum, plasma, cell supernatant, tissue homogenate

Method: Sandwich ELISA

3. Recombinant Human DPP-4 Protein

Catalog No.: UAxxxx

Purity: ≥95%

Application: Enzyme activity assay, inhibitor screening

4. DPP-4 Substrate & Activity Detection Kit

Brand: Absin

Features: High sensitivity, stable signal

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.